CMX-001 (California Pacific Medical Center)

N/A

Report date: 2025/06/11 20:01:15

Base Information

Drug NameCMX-001 (California Pacific Medical Center)
Drug Alias NameCMV-targeting immune cell vaccine (California Pacific)
ClassificationCell and gene therapy > Cell therapyVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsGlioblastoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsYes
Global Highest StatusPending (Clinical)
Highest Status in ChinaN/A
Originator CompaniesCalifornia Pacific Medical Center
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCalifornia Pacific Medical Center
Active IndicationsN/A
Inactive IndicationsGlioblastoma

Other Information

ATC CodeN/A
Related LinksN/A